标题
The Yin and Yang of Toll-like receptors in cancer
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 27, Pages 3485-3495
出版商
Springer Nature
发表日期
2013-08-12
DOI
10.1038/onc.2013.302
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice
- (2013) Ziyan Wang et al. HEPATOLOGY
- Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK
- (2013) Clemens Neufert et al. JOURNAL OF CLINICAL INVESTIGATION
- Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APCMin/+ mice
- (2013) Y Li et al. ONCOGENE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Victories and deceptions in tumor immunology
- (2013) Guido Kroemer et al. OncoImmunology
- Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
- (2012) Giorgio Trinchieri Annual Review of Immunology
- Regulation of wound healing and organ fibrosis by toll-like receptors
- (2012) Peter Huebener et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC Min/+ mice
- (2012) Yinghui Li et al. CARCINOGENESIS
- Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
- (2012) Jieun Lee et al. CELL
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Profiles of Gene Polymorphisms in Cytokines and Toll-Like Receptors with Higher Risk for Gastric Cancer
- (2012) Juliana Garcia de Oliveira et al. DIGESTIVE DISEASES AND SCIENCES
- Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice
- (2012) Heng Lin et al. HEPATOLOGY
- Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors
- (2012) Philipp Yu et al. IMMUNITY
- The application of Toll like receptors for cancer therapy
- (2012) Eui Young So et al. International Journal of Biological Sciences
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis
- (2012) Christophe Cataisson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
- (2012) Valerie Chew et al. JNCI-Journal of the National Cancer Institute
- The price of immunity
- (2012) Romina S Goldszmid et al. NATURE IMMUNOLOGY
- Anticancer TLR agonists on the ropes
- (2012) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
- (2012) M. Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
- (2012) H. Shime et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- Presently available biosimilars in hematology-oncology: G-CSF
- (2012) Pere Gascon Targeted Oncology
- Synbiotics in Health and Disease
- (2012) Sofia Kolida et al. Annual Review of Food Science and Technology
- Signaling in Innate Immunity and Inflammation
- (2012) K. Newton et al. Cold Spring Harbor Perspectives in Biology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice
- (2011) Timea Csak et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
- (2011) S. I. Grivennikov et al. ANNALS OF THE RHEUMATIC DISEASES
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Inflammatory Mechanisms in Obesity
- (2011) Margaret F. Gregor et al. Annual Review of Immunology
- Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
- (2011) S. Nierkens et al. CANCER RESEARCH
- Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
- (2011) Z. Cai et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
- (2011) Marko Babjuk et al. EUROPEAN UROLOGY
- Tumor Promotion via Injury- and Death-Induced Inflammation
- (2011) Ali Kuraishy et al. IMMUNITY
- Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod
- (2011) Elizabeth C. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mitochondrial reactive oxygen species drive proinflammatory cytokine production: Figure 1.
- (2011) Edwina Naik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Single Nucleotide Polymorphisms of Toll-Like Receptor 4 Decrease the Risk of Development of Hepatocellular Carcinoma
- (2011) Shi Minmin et al. PLoS One
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells
- (2010) Deepak Mittal et al. EMBO JOURNAL
- Lack of Commensal Flora in Helicobacter pylori–Infected INS-GAS Mice Reduces Gastritis and Delays Intraepithelial Neoplasia
- (2010) Jennifer L. Lofgren et al. GASTROENTEROLOGY
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- Impact of Toll-like receptor 4 polymorphisms on risk of cancer
- (2010) Anton G. Kutikhin HUMAN IMMUNOLOGY
- Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
- (2010) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation
- (2010) Takashi Ebihara et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Significant association between toll-like receptor gene polymorphisms and gallbladder cancer
- (2010) Kshitij Srivastava et al. LIVER INTERNATIONAL
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
- (2010) Xiaoxia Z. West et al. NATURE
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer
- (2010) Emily L. Lowe et al. PLoS One
- Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
- (2009) W. Elliot Love et al. ARCHIVES OF DERMATOLOGY
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats
- (2009) R. K. Le Leu et al. CARCINOGENESIS
- A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action
- (2009) V. Damiano et al. CLINICAL CANCER RESEARCH
- Impact of Toll-like receptors [TLR] 2 (−196 to −174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women
- (2009) Saumya Pandey et al. GYNECOLOGIC ONCOLOGY
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
- (2009) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7
- (2009) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo
- (2009) Tao Ren et al. PATHOLOGY & ONCOLOGY RESEARCH
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
- (2008) Toshiharu Sakurai et al. CANCER CELL
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
- Protective Role of Toll-like Receptor 4 during the Initiation Stage of Cutaneous Chemical Carcinogenesis
- (2008) N. Yusuf et al. CANCER RESEARCH
- Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer
- (2008) Sang Hoon Rhee et al. GASTROENTEROLOGY
- Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
- (2008) Ron N. Apte et al. IMMUNOLOGICAL REVIEWS
- Tumour immunity: effector response to tumour and role of the microenvironment
- (2008) Alberto Mantovani et al. LANCET
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
- Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
- (2008) J. B. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started